Steroids And Protein-Conjugates Thereof
「Steroids And Protein-Conjugates Thereof」对应一条老挝专利公开记录,由 Regeneron Pharmaceuticals, Inc 于 2017-11-07 提交申请,当前状态为等待形式审查。关键编号与类型标注为 申请号 P/900 / DIP 编号 LAP900 / 主管局代码 LA / 保护类型 Patent - PCT National Phase。时间线要点:公开/公告日 2026-04-03。国际分类 / IPC 标注为 A61K 31/58、A61P 29/00、A61P 35/00。发明人 / 设计人包括 Amy HAN (US);、Andrew MURPHY J. (US);、William OLSON (US);。代理机构 / 代理人记载为 Tilleke & Gibbins Lao Co., Ltd。公开摘要提示:Described herein protein steroid conjugates whereby a glucocorticoid compound is conjugated to a binding agent which is preferably an antib…。
This Laos patent “Steroids And Protein-Conjugates Thereof” is a public DIP intellectual-property record, filed by Regeneron Pharmaceuticals, Inc on 2017-11-07; current status: Awaiting formal examination. Identifiers include application No. P/900; DIP id LAP900; protection kind Patent - PCT National Phase. Key dates: publication 2026-04-03. Classification: A61K 31/58、A61P 29/00、A61P 35/00. Inventor(s)/designer(s): Amy HAN (US);, Andrew MURPHY J. (US);, William OLSON (US);. Abstract hint: Described herein protein steroid conjugates whereby a glucocorticoid compound is conjugated to a binding agent which is preferably an antib…. This prose is informational only and does not constitute legal advice, ownership proof or an infringement opinion.
ສິດທິບັດ «Steroids And Protein-Conjugates Thereof» ເປັນຂໍ້ມູນຊັບສິນທາງປັນຍາເປີດເຜີຍຂອງ DIP, ຍື່ນໂດຍ Regeneron Pharmaceuticals, Inc ໃນວັນທີ 2017-11-07; ສະຖານະ ລໍຖ້າກວດຮູບແບບ. ຕົວລະບຸ: ເລກທີຄຳຮ້ອງ P/900; ລະຫັດ DIP LAP900; ປະເພດການປົກປ້ອງ Patent - PCT National Phase. ວັນທີສຳຄັນ: ວັນເຜີຍແຜ່ 2026-04-03. ປະເພດ/ຫ້ອງ: A61K 31/58、A61P 29/00、A61P 35/00. ນັກປະດິດ/ນັກອອກແບບ: Amy HAN (US);, Andrew MURPHY J. (US);, William OLSON (US);. ສະຫຼຸບ: Described herein protein steroid conjugates whereby a glucocorticoid compound is conjugated to a binding agent which is preferably an antib…. ຂໍ້ຄວາມນີ້ເນັ້ນຕົວເລກ, ວັນທີ, ປະເພດ ແລະ ຜູ້ຍື່ນ ເພື່ອຫຼຸດຄວາມຄ້າຍຄືນລະຫວ່າງໜ້າ IP; ກວດຂໍ້ມູນທາງການກ່ອນຕັດສິນໃຈ.
P/900
图样
基础信息
- 类型
- 专利
- 申请号
P/900- 状态
- 等待形式审查
- 申请人
- Regeneron Pharmaceuticals, Inc
- 代理机构
- Tilleke & Gibbins Lao Co., Ltd
- 申请日期
- 2017-11-07
- 公开/公告日
- 2026-04-03
- 国际分类
- A61K 31/58 · A61P 29/00 · A61P 35/00
- 商品 / 服务
- —
办理流程
根据当前状态动态标注-
提交申请
-
形式审查 进行中
-
实质审查
-
公开
-
授权
关联分析
LaoBiz 企业数据库联动类似专利推荐
摘要
Described herein protein steroid conjugates whereby a glucocorticoid compound is conjugated to a binding agent which is preferably an antibody. These are useful, for example, for the target-specific delivery of glucocorticoids (GCs) to cells.
Described herein protein steroid conjugates whereby a glucocorticoid compound is conjugated to a binding agent which is preferably an antibody. These are useful, for example, for the target-specific delivery of glucocorticoids (GCs) to cells.